CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of chemotherapeutic
pancreatic cyst ablation using ethanol lavage followed by the infusion of a dual-agent
chemotherapeutic cocktail (paclitaxel + gemcitabine) compared with alcohol-free saline lavage
followed by infusion of the same dual-agent chemotherapeutic cocktail (paclitaxel +
gemcitabine) for the ablation of pancreatic cystic neoplasms using endoscopic ultrasound
guided fine needle infusion (EUS-FNI) for agent delivery.